FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $922,480 | -62.5% | 435,132 | -15.9% | 0.00% | – |
| Q2 2023 | $2,461,672 | -51.1% | 517,158 | -41.4% | 0.00% | -100.0% |
| Q1 2023 | $5,030,331 | +671.5% | 882,514 | +1265.8% | 0.00% | – |
| Q4 2022 | $651,986 | -81.7% | 64,617 | -59.4% | 0.00% | -100.0% |
| Q3 2022 | $3,570,000 | -36.7% | 159,342 | -30.0% | 0.00% | -50.0% |
| Q2 2022 | $5,638,000 | +9.0% | 227,552 | +70.6% | 0.00% | – |
| Q1 2022 | $5,172,000 | -74.8% | 133,413 | -61.9% | 0.00% | – |
| Q4 2021 | $20,502,000 | +24.5% | 350,406 | +26.1% | 0.00% | -100.0% |
| Q3 2021 | $16,472,000 | +11.4% | 277,914 | +63.2% | 0.00% | 0.0% |
| Q2 2021 | $14,781,000 | -33.7% | 170,308 | -37.1% | 0.00% | -50.0% |
| Q1 2021 | $22,307,000 | -32.0% | 270,557 | -25.0% | 0.00% | +33.3% |
| Q4 2020 | $32,822,000 | +193.9% | 360,958 | +29.2% | 0.00% | +50.0% |
| Q3 2020 | $11,168,000 | +10.5% | 279,384 | -5.1% | 0.00% | -33.3% |
| Q2 2020 | $10,103,000 | +107.6% | 294,479 | +34.4% | 0.00% | +200.0% |
| Q1 2020 | $4,866,000 | -55.7% | 219,110 | -61.0% | 0.00% | -75.0% |
| Q4 2019 | $10,986,000 | +51.9% | 561,357 | +20.6% | 0.00% | +100.0% |
| Q3 2019 | $7,232,000 | -75.4% | 465,634 | -67.9% | 0.00% | -33.3% |
| Q2 2019 | $29,447,000 | +332.8% | 1,450,480 | +274.5% | 0.00% | +50.0% |
| Q1 2019 | $6,804,000 | +112.0% | 387,300 | +54.8% | 0.00% | 0.0% |
| Q4 2018 | $3,210,000 | +18.9% | 250,200 | +50.9% | 0.00% | +100.0% |
| Q3 2018 | $2,700,000 | +133.6% | 165,800 | +62.7% | 0.00% | – |
| Q2 2018 | $1,156,000 | +13.7% | 101,895 | -2.2% | 0.00% | – |
| Q1 2018 | $1,017,000 | +239.0% | 104,134 | +111.9% | 0.00% | – |
| Q4 2017 | $300,000 | – | 49,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |